Status: current, Defined. Date: 31-May 2022. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4704421000168114 | Prolanza ODT (olanzapine 5 mg) orally disintegrating tablet, 14 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4704431000168112 | Prolanza ODT 5 mg orally disintegrating tablet, 14 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Prolanza ODT 5 mg orally disintegrating tablet, 14 | Is a | olanzapine 5 mg orally disintegrating tablet, 14 | true | Inferred relationship | Some | ||
| Prolanza ODT 5 mg orally disintegrating tablet, 14 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Prolanza ODT 5 mg orally disintegrating tablet, 14 | has TP | Prolanza ODT | true | Inferred relationship | Some | ||
| Prolanza ODT 5 mg orally disintegrating tablet, 14 | has TPUU | Prolanza ODT 5 mg orally disintegrating tablet | true | Inferred relationship | Some | 1434024414 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Prolanza ODT 5 mg orally disintegrating tablet, 14, blister pack | Is a | True | Prolanza ODT 5 mg orally disintegrating tablet, 14 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR